MDLN vs RMD: stock comparison and AI forecast
Medline Inc. (MDLN) and Resmed Inc (RMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MDLN Medline Inc.
- Market Cap
- $52.27B
- P/E Ratio
- 180.7x
- Size
- large-cap
- AI Forecast
RMD Resmed Inc
- Price
- $240.51 +14.7% · 6M
- Market Cap
- $33.83B
- P/E Ratio
- 21.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MDLN is 1.5 times larger than RMD by market capitalization ($52.27B against $33.83B).
- RMD trades at 21.9 times trailing earnings, MDLN at 180.7 times.
- MDLN carries 1.76 times debt per unit of equity, against 0.38 times for RMD.
- RMD yields 1.05% in dividends; MDLN pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MDLN | RMD |
|---|---|---|
| Market Cap | $52.27B | $33.83B |
| P/E Ratio | 180.73x | 21.90x |
| P/B Ratio | 4.43x | 5.69x |
| Dividend Yield | – | 1.05% |
| EPS | $0.22 | $10.98 |
| Book Value/Share | $8.98 | $42.29 |
| Revenue/Share | $22.82 | $40.76 |
| FCF/Share | $1.62 | $11.44 |
Profitability & Margins
| Metric | MDLN | RMD |
|---|---|---|
| ROE | – | 26.8% |
| ROA | – | 19.4% |
| ROIC | 5.0% | 27.5% |
| Gross Margin | 26.2% | 61.1% |
| Operating Margin | 6.2% | 33.0% |
| Net Margin | – | 27.8% |
| EBT Margin | 4.1% | 35.1% |
| Tax Rate | 19.5% | 20.8% |
Financial Health
| Metric | MDLN | RMD |
|---|---|---|
| Current Ratio | 4.04x | 2.65x |
| Quick Ratio | 2.51x | 1.88x |
| D/E Ratio | 1.76x | 0.38x |
| Financial Leverage | 3.40x | 1.38x |
| Interest Coverage | 1.4x | 99.0x |
| Working Capital | $9.52B | $2.18B |
Cash Flow
| Metric | MDLN | RMD |
|---|---|---|
| Operating Cash Flow | $2.59B | $1.77B |
| Free Cash Flow | $2.13B | $1.61B |
| Capital Spending | -$460M | -$162M |
| OCF Growth YoY | – | -6.0% |
| FCF Growth YoY | – | -9.0% |
| FCF/Sales | 7.1% | 28.1% |
| CapEx/Sales | 1.5% | 2.8% |
Operational Efficiency
| Metric | MDLN | RMD |
|---|---|---|
| Asset Turnover | 0.75x | 0.70x |
| Receivables Turnover | 7.9x | 5.9x |
| Inventory Turnover | 4.6x | 2.2x |
| Fixed Assets Turnover | 6.3x | 9.5x |
| Days Sales Outstanding | 46 days | 62 days |
| Days Inventory | 79 days | 167 days |
| Payables Period | 20 days | 52 days |
| Cash Conversion Cycle | 105 days | 177 days |
Income Statement
| Metric | MDLN | RMD |
|---|---|---|
| Total Revenue | $30.00B | $5.73B |
| Operating Income | $1.87B | $1.89B |
| Net Income | – | $1.59B |
| R&D Expense | – | $394M |
| SG&A Expense | $4.91B | $1.18B |
| Cost of Goods Sold | $22.14B | $2.23B |
Dividend & Shareholder Information
| Metric | MDLN | RMD |
|---|---|---|
| Dividends Per Share | – | $2.54 |
| Payout Ratio | – | 23.1% |
| Shares Outstanding | 1315M | 141M |
| Net Income Growth | – | 10.8% |
| EPS Growth | – | 12.4% |
MDLN vs RMD: stock comparison and AI forecast
Which is bigger, MDLN or RMD?
MDLN is 1.5 times larger than RMD by market capitalization ($52.27B against $33.83B).
Which is cheaper on earnings, MDLN or RMD?
RMD trades at 21.9 times trailing earnings, MDLN at 180.7 times.
Which one does Intratio's AI model rank higher, MDLN or RMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.